{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:44Z","timestamp":1791218144608,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000171.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000}}],"reference-count":48,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000171.pub3","type":"journal-article","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T12:38:07Z","timestamp":1263818287000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Treatment of latent tuberculosis infection in HIV infected persons"],"prefix":"10.1002","author":[{"given":"Christopher","family":"Akolo","sequence":"first","affiliation":[{"name":"University of Oxford; Department of Public Health; Oxford UK OX3 7LF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifedayo","family":"Adetifa","sequence":"additional","affiliation":[{"name":"Medical Research Council (UK) Laboratories; Bacterial Diseases Programme; Atlantic Boulevard, Fajara PO Box 273 Banjul Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Shepperd","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Public Health; Oxford UK OX3 7LF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Volmink","sequence":"additional","affiliation":[{"name":"Stellenbosch University; Faculty of Health Sciences; PO Box 19063 Tygerberg South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD000171.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00042560-200111010-00018","article-title":"No effect of isoniazid prophylaxis for purified protein derivative-negative HIV infected adults living in a country endemic tuberculosis: results of a randomized trial","volume":"28","author":"Fitzgerald","year":"2001","journal-title":"Journal of Acquuired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199707313370505","article-title":"A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis","volume":"337","author":"Gordin","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-Infected persons. An international randomized trial","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"issue":"9105","key":"10.1002\/14651858.CD000171.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomized trial of isoniazid versus rifampicine and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00002030-199707000-00006","article-title":"Isoniazid preventive therapy for tuberculosis in HIV-1 infected adults: results of a randomized controlled trial","volume":"11","author":"Hawken","year":"1997","journal-title":"AIDS"},{"issue":"5","key":"10.1002\/14651858.CD000171.pub3-BIB0006|cit6","first-page":"161","article-title":"Evaluation of 2 tuberculosis chemoprohylaxis regimens in patients infected with human immunodeficiency virus. The Gecmei Group","volume":"115","author":"Martinez","year":"2000","journal-title":"Medicina Clinica (Barcelona)"},{"issue":"10","key":"10.1002\/14651858.CD000171.pub3-BIB0007|cit7","first-page":"1114","article-title":"Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease","volume":"11","author":"Mohammed","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape","year":"1993","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200101260-00011","article-title":"Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian Adults","volume":"15","author":"Quigley","year":"2001","journal-title":"AIDS"},{"issue":"6","key":"10.1002\/14651858.CD000171.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0213-005X(03)72942-5","article-title":"A randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy","volume":"21","author":"Rivero","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"5","key":"10.1002\/14651858.CD000171.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1157\/13102265","article-title":"A Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients","volume":"25","author":"Rivero","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"4","key":"10.1002\/14651858.CD000171.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1310\/hct0704-172","article-title":"Effect of Tuberculosis Preventive Therapy on HIV Disease Progression and Survival in HIV-Infected Adults","volume":"7","author":"Lim","year":"2006","journal-title":"HIV Clin Trials"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus","volume":"337","author":"Whalen","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus.","volume":"337","author":"Whalen","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(00)02870-1","volume":"356","author":"Fitzgerald","year":"2000","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0017|cit17","unstructured":"Gracia ML Valdespino JL Garcia-Sancho C Weissenbacher M Daniels E Peruga A Palacios M Loo E Cruz C Lina JL Luna M Mayar ME Romero C Pineda L Sepulveda J Compliance and side effects to chemoprophylaxis for TB in HIV+. Mexican experience IX International Conference on AIDS 1993"},{"issue":"22","key":"10.1002\/14651858.CD000171.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.293.22.2719","article-title":"Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental study","volume":"293","author":"Grant","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0019|cit19","unstructured":"Matteelli A Carosi G Signorini L Tebaldi A Caligaris S Gulletta M Multinational study for preventive therapy of latent tuberculosis in HIV positive individuals: isoniazid vs. rifabutin 12th World AIDS Conference 1998"},{"issue":"5","key":"10.1002\/14651858.CD000171.pub3-BIB0020|cit20","first-page":"285","volume":"79","author":"Saenghirunvattana","year":"1996","journal-title":"J. Med Association Thai"},{"issue":"3","key":"10.1002\/14651858.CD000171.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1086\/431482","article-title":"Lessons Learned from Use of Highly Active Antiretroviral Therapy in Africa","volume":"41","author":"Akileswaran","year":"2005","journal-title":"Clinical Infectious Disease"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1164\/ajrccm\/142.3.725","article-title":"Medical Section of the American Lung Association. Diagnostic standards and classification of tuberculosis","volume":"142","author":"American Thoracic Society (ATS)","year":"1990","journal-title":"Am Rev Resp Dis"},{"issue":"9323","key":"10.1002\/14651858.CD000171.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD000171.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3201\/eid1205.050681","volume":"12","author":"Balcells M.","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0025|cit25","first-page":"1","article-title":"Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations","volume":"47","author":"CDC","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/518662","article-title":"Tuberculosis Preventive Therapy in the Era of HIV Infection: Overview and Research Priorities","volume":"196","author":"Churchyard","year":"2007","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0027|cit27","first-page":"187","article-title":"Immunology of Tuberculosis","volume-title":"Tuberculosis: A comprhensive international approach","author":"Daniel","year":"2000"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD000171.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0030|cit30","first-page":"241","article-title":"The association between HIV and tuberculosis in the developing world","volume-title":"Clinical tuberculosis","author":"Harries","year":"1994"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"18","key":"10.1002\/14651858.CD000171.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","volume":"19","author":"Lawn S.","year":"2005","journal-title":"AIDS"},{"issue":"4","key":"10.1002\/14651858.CD000171.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1310\/hct0704-172","article-title":"Effect of Tuberculosis Preventive Therapy on HIV Disease Progression and Survival in HIV-Infected Adults","volume":"7","author":"Lim","year":"2006","journal-title":"HIV Clin Trials"},{"issue":"2","key":"10.1002\/14651858.CD000171.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/0956462053057576","volume":"16","author":"McShane","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0035|cit35","volume":"Idm009","author":"Mendelson","year":"2007","journal-title":"Br Med Bull."},{"issue":"3","key":"10.1002\/14651858.CD000171.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.ede.0000259985.76928.64","volume":"18","author":"Nelson","year":"2007","journal-title":"Epidemiology"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0037|cit37","first-page":"151","article-title":"Preventive therapy for tuberculosis","volume-title":"Tuberculosis: back to the future","author":"O'Brien","year":"1994"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Eng J Med"},{"issue":"1. Art. No.: CD","key":"10.1002\/14651858.CD000171.pub3-BIB0039|cit39","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons (Cochrane Review)","author":"Smieja","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0040|cit40","first-page":"895","article-title":"Tuberculin reactivity and the risk of tuberculosis: a review.","volume":"4","author":"Watkins","year":"2000","journal-title":"Int J Tubercle & Lung Dis"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0041|cit41","unstructured":"World Health Organization (WHO) and UNAIDS Policy statement on preventive therapy against tuberculosis in people living with HIV: Report of a meeting held in Geneva, 18-20 February 1998 WHO\/TB\/98.255, UNAIDS\/98.34"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0042|cit42","unstructured":"WHO World Health Organisation, Geneva, Switzerland. 2004"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0043|cit43","unstructured":"WHO WHO report 2008 Geneva, Switzerland 2008"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0044|cit44","unstructured":"WHO Report of a joint World Health Organization HIV\/AIDS and TB Department meeting, 2-4 April 2008, Geneva, Switzerland. Geneva, WorldHealth Organization, 2008. http:\/\/www.who.int\/hiv\/pub\/meetingreports\/WHO_3Is_meeting_report.pdf, accessed 10 January, 2009"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0045|cit45","unstructured":"WHO WHO report 2009 Geneva, Switzerland. http:\/\/www.who.int\/tb\/publications\/global_report\/2009\/pdf\/full_report.pdf, accessed 30 March, 2009"},{"issue":"5639","key":"10.1002\/14651858.CD000171.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1126\/science.1086845","volume":"301","author":"Williams B.","year":"2003","journal-title":"Science"},{"key":"10.1002\/14651858.CD000171.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.317.7159.625","article-title":"Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials","volume":"317","author":"Wilkinson","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD000171.pub3-BIB0048|cit48","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Woldehanna","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000171.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:54:56Z","timestamp":1628542496000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000171.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane HIV\/AIDS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000171.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]}}}